Advisors Asset Management, Inc. Neurocrine Biosciences Inc Transaction History
Advisors Asset Management, Inc.
- $5.1 Billion
- Q1 2025
A detailed history of Advisors Asset Management, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 36,761 shares of NBIX stock, worth $4.58 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
36,761
Previous 36,395
1.01%
Holding current value
$4.58 Million
Previous $4.97 Million
18.16%
% of portfolio
0.08%
Previous 0.09%
Shares
28 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.77 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.24 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$690 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$606 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$333 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...